Amelia I. M.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of MEDI5752 in Patients with Advanced Solid Tumors: A Clinical Trial
- A Phase Ib/II Study of Rilvegostomig and Ramucirumab in Participants with Advanced or Metastatic Non-Small Cell Lung Cancer
- Comparison of Sotorasib Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in PD-L1 Negative KRAS p.G12C Positive Advanced Non-Squamous NSCLC
Data & Insights
Has run more than one trial at 328 of 582 partner sites.
Specializations
Lung Cancer Therapeutics
This investigator specializes in advanced treatment approaches for non-small cell lung cancer (NSCLC), with particular emphasis on metastatic disease states. Their research encompasses innovative therapeutic strategies, focusing on immunotherapy-based treatment combinations.
- Advanced NSCLC Management
- Metastatic Disease Treatment
- Combination Therapy Approaches
The investigator's work extends to evaluating novel therapeutic combinations for patients without actionable genomic alterations.
Precision Oncology
Research interests include targeted approaches for specific molecular subtypes, particularly focusing on KRAS G12C mutations in lung cancer. The investigator evaluates biomarker-driven treatment strategies and their impact on patient outcomes.
- Molecular Targeting
- Biomarker Assessment
- Treatment Personalization
Their work involves assessing treatment efficacy in specific patient populations based on molecular characteristics.
Immunotherapy Innovation
The investigator explores novel immunotherapeutic approaches in oncology, including evaluation of new agents and their combinations with established treatments. Their research encompasses both monotherapy and combination strategies for refractory disease.
- Novel Immunotherapy Agents
- Combination Protocols
- Treatment Resistance
Expertise includes assessment of treatment responses in relapsed and refractory cancer settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.